Why Are Brazilian Health Insurance Premiums Rising? An In-Depth Look

For millions of Brazilians, private health insurance—known as planos de saúde—is a necessity. With the public Unified Health System (SUS) often overcrowded, a good plano offers faster access to specialists, diagnostic tests, and hospital care. Yet over the past five years, premiums have skyrocketed, outpacing general inflation and squeezing household budgets.

In 2023 alone, the National Supplementary Health Agency (ANS) approved an annual adjustment of 9.63% for individual plans, while corporate plans saw increases sometimes exceeding 15–20%. This trend shows no signs of slowing. But what exactly is driving these relentless price hikes? This article takes a deep dive into the economic, regulatory, medical, and structural forces behind Brazil’s rising health insurance costs.

Table of Contents

How Big Is Brazil’s Private Health Insurance Market?

Brazil has one of the largest private health insurance markets in the world. As of 2024, over 50 million beneficiaries are covered by some form of private health plan—roughly one in four Brazilians. The sector generates more than R$ 200 billion in annual revenues and accounts for a significant portion of the country’s healthcare expenditure.

The market is dominated by a mix of large insurance companies such as Bradesco Saúde, SulAmérica, Amil, NotreDame Intermédica (Hapvida), and Unimed, the largest cooperative system. Plans range from basic ambulatory coverage to comprehensive hospital care with private rooms.

For a broader introduction to how these plans function, see our guide: Navigating 'Planos de Saúde': An Introduction to Brazil's Private Health Insurance.

The Core Drivers of Premium Increases

Premium increases are never caused by a single factor. Rather, they result from a combination of medical inflation, demographic shifts, regulatory burdens, legal costs, technological advancements, and economic volatility. Let’s examine each in detail.

1. Medical Inflation Outpaces General Inflation

Medical inflation in Brazil regularly runs three to five times higher than the official IPCA (consumer price index). In 2023, while IPCA was around 4.6%, medical costs rose by more than 12%. This gap is structural and reflects several underlying pressures:

Higher drug prices: Brazil imports many active pharmaceutical ingredients. Currency depreciation and global supply chain disruptions drive up costs.
Expensive new technologies: Robotic surgery, advanced imaging (PET-CT, 3T MRI), and precision medicine are increasingly incorporated into coverage.
Hospital cost inflation: Wages for doctors, nurses, and support staff rise faster than the economy. Hospital operating costs (energy, sterilization, equipment maintenance) also increase.

Insurance companies pass these cost increases to consumers through higher premiums. Unlike other sectors, healthcare has limited productivity gains—you cannot easily “produce” more doctor consultations in the same time without sacrificing quality.

2. Aging Population and Increased Utilization

Brazil is aging rapidly. In 2010, people over 60 made up 11% of the population; by 2030, that share is projected to reach 18%. Older beneficiaries consume far more healthcare services:

Chronic disease management: Diabetes, hypertension, heart disease, and kidney failure require continuous treatment, medications, and hospitalizations.
Cancer and degenerative conditions: Incidence of cancer rises with age, and treatments are expensive (surgery, chemotherapy, immunotherapy).
Longer hospital stays: Elderly patients often require extended recovery periods.

Moreover, younger and healthier beneficiaries are increasingly opting out of private plans due to high costs, leaving a risk pool that is older and sicker. This adverse selection forces insurers to raise premiums across the board.

3. Regulatory Costs and the Role of ANS

The Agência Nacional de Saúde Suplementar (ANS) sets strict rules for plan coverage, pricing, and quality. While regulation ensures consumer protection, it also imposes costs:

Mandatory coverage list (Rol de Procedimentos): The ANS regularly updates the list of procedures and treatments that plans must cover. In 2023, the list expanded to include dozens of new items, including gene therapies, CAR-T cell therapy, and robotic-assisted surgery. Each new addition raises the expected cost of a plan.
Minimum reserve requirements: Insurers must hold larger capital reserves, limiting their ability to invest or moderate pricing.
Reimbursement floors: Many hospitals and doctors negotiate minimum reimbursement rates, and ANS often sets minimum payment standards.

For a complete understanding of how ANS influences your rights and plan dynamics, read: The Role of ANS: Understanding Health Insurance Regulation and Your Rights in Brazil.

4. Judicialization of Health

Brazil has seen an explosion of health litigation—individuals suing insurance companies and the government to force coverage of treatments not included in their plan. This phenomenon, known as judicialização da saúde, has massive financial implications:

Courts often order plans to cover experimental drugs, off-label treatments, or procedures outside the ANS rol.
Insurers lose approximately 70–80% of these lawsuits, partly because judges prioritize the right to life over contractual limits.
The cost of defending lawsuits (legal fees, compliance) adds to operational expenses.
In 2022, Brazil’s Superior Court of Justice (STJ) ruled that the ANS rol is not exhaustive—meaning insurers can be forced to cover anything, further increasing uncertainty.

Insurers must price in these unpredictable legal costs. The result: premiums are loaded with a “judicial risk premium.” A 2023 study by the IESS (Institute for Supplementary Health Studies) estimated that judicialization added R$ 15 billion per year to the sector’s costs.

5. Hospital and Network Consolidation

The Brazilian hospital market is increasingly concentrated. Large groups like Rede D’Or, Hapvida, Dasa, and Unimed now dominate many regions. Consolidation gives these providers greater bargaining power:

They can demand higher reimbursement rates from insurers.
They may refuse to contract with insurers that resist price increases.
Some large groups also operate their own insurance plans, creating vertical integration and reducing competition.

For consumers, this means narrower networks and higher premiums if your plan includes top-tier hospital chains. Understanding your network options is crucial: Choosing a Hospital Network in Brazil: What Your Health Plan Determines.

6. Technological Innovation and New Treatments

Modern medicine is advancing faster than ever. While great for patients, it stresses insurance finances:

Immunotherapies for cancer cost R$ 200,000–R$ 500,000 per patient per year.
Gene therapies like Zolgensma (for spinal muscular atrophy) cost around R$ 10 million per dose.
Robotic surgery (Da Vinci system) increases procedural costs by 30–50%.
Continuous glucose monitors for diabetics add R$ 200–R$ 400 per month per patient.

Insurers cannot easily deny these treatments once the ANS mandates coverage. They must spread the cost across the entire premium base. Even a small number of high-cost cases can significantly raise average premiums.

7. Fraud, Waste, and Abuse

Brazil’s health insurance sector estimates that fraud and waste account for 10–15% of all claims costs. Examples include:

Billing for services not performed (phantom consultations, tests).
Upcoding (charging for a more expensive procedure than actually done).
Unnecessary hospital admissions or prolonged stays.
Kickbacks between providers and patients (e.g., unrealistic physiotherapy sessions).

Insurers invest in auditing and analytics to combat fraud, but the costs of anti-fraud programs themselves add to premiums. The industry has been pushing for tougher legislation, but progress is slow.

8. The Post-COVID Catch‑Up Effect

The COVID-19 pandemic created a unique distortion. During 2020–2021, lockdowns and fear reduced demand for elective procedures, diagnostic exams, and routine care. Many insurers saw a temporary dip in claim costs and even offered premium discounts or freezes.

However, from mid-2022 onwards, a massive catch‑up wave occurred. Patients who postponed surgeries (hip replacements, cardiac procedures, cancer screenings) flooded hospitals. Additionally, long COVID patients require ongoing specialist care. The cumulative effect was a surge in claim costs of 15–20% across many carriers.

Insurers are now pricing in a return to “normal” elevated utilization, plus the residual costs from deferred care.

9. Economic Factors: Inflation, Currency, and Interest Rates

Brazil’s macroeconomic environment plays a large role:

Weakening real: Many medical inputs (syringes, catheters, pharmaceuticals) are imported. A weaker real raises costs.
High interest rates: Insurers earn investment income on reserves. When interest rates are high (Selic at 10.5–13.75% during 2022–2024), they can offset some costs. But if rates drop, premiums must compensate.
General inflation (IPCA near 10% in 2022) pushed up wages and energy costs, which hospitals pass to insurers.

All these factors create a volatile environment where premium adjustments must anticipate future economic conditions, not just historical costs.

Individual vs. Corporate Plans: Different Cost Dynamics

One of the most important distinctions in the Brazilian market is between individual plans (purchased directly by consumers) and corporate plans (offered through employers). Their cost structures differ significantly.

Comparative Table: Individual vs. Corporate Health Plan Premiums

Aspect	Individual Plans	Corporate Plans
Annual adjustment	Regulated by ANS (single % for all)	Free negotiation between insurer and employer
Typical 2023 increase	9.63% (approved)	12–18% on average
Risk pool	Older, higher morbi-disease	Younger, healthier (employed)
Judicialization impact	High; individuals sue more often	Medium; companies manage large blocks
Insurer pricing power	Fixed by ANS, less flexibility	Flexible—insurers bid for contracts
Portability restrictions	Strict rules	Easier when changing jobs
Cost for plan with same benefits	Usually higher per beneficiary	Lower per beneficiary but varies by group size

For a deeper breakdown, read: Individual vs. Corporate Health Plans in Brazil: Key Differences Explained.

Why Corporate Plans See Faster Premium Growth

Although individual plan adjustments are capped, corporate premiums have been rising faster. Why?

Employers often demand richer benefits to attract talent (e.g., unlimited psychotherapy, dental, wellness programs).
Corporate contracts renew every 12 months with no ANS price ceiling—so insurers can fully pass on medical inflation.
Claims experience in a specific company can be volatile; a single high-cost case (cancer, premature infant) can spike rates by 20–30% the next year.
Many small and medium companies lack the bargaining power to negotiate discounts.

Impact on Brazilian Consumers and Employers

The relentless rise in premiums is reshaping behaviour:

Switching plans: More consumers are opting for cheaper, narrower network plans or ambulatory-only cover (without hospitalization).
Dropping coverage: The number of beneficiaries has stagnated or slightly declined in recent years, especially among low- and middle-income families.
Employer cost shifting: Companies are raising employee co-payments (coparticipação) or switching to corporate health insurance models where the employee pays a portion of the premium.
Growth of low-cost plans: Insurers like Hapvida and Prevent Senior have gained market share by offering affordable plans with restricted networks.

A recent study by the Brazilian Institute of Geography and Statistics (IBGE) showed that in 2023, 30% of Brazilians who previously had private insurance reported dropping it due to cost. This puts more pressure on the already strained SUS.

What Can Be Done to Control Premiums?

Insurance companies, regulators, and consumers all ask: is there a solution? While no magic bullet exists, several strategies are being deployed.

A. Preventive Medicine and Wellness Programs

Insurers are investing heavily in preventive care—health coaching, chronic disease management, vaccination campaigns, and check‑ups. The goal is to reduce costly hospitalizations. Early data from programs like Bradesco Saúde’s Longevity Plan show a 10–15% reduction in emergency room visits among enrolled members.

B. Telemedicine and Digital Health

Tele-consultations exploded during COVID and remain popular. A telemedicine visit costs insurers roughly R$ 60–R$ 120, compared to R$ 200–R$ 400 for an in‑person specialist visit. Telediagnostics (remote analysis of radiology images, digital ECGs) also reduce waste.

C. Network Management and Steerage

Insurers are creating value‑based networks where hospitals and doctors are paid based on outcomes rather than fee‑for‑service. They also steer patients to high‑quality, cost‑efficient providers. This requires a careful balance—too much restriction drives consumers away.

For tips on evaluating provider networks, check: Choosing a Hospital Network in Brazil: What Your Health Plan Determines.

D. Technology for Fraud Detection

AI and machine learning are being used to flag suspicious claims patterns. SulAmérica, for example, reported saving R$ 1.2 billion in 2023 through automated fraud detection tools.

E. Regulatory Reform

The ANS is under pressure to create a more flexible regulatory environment—for instance, allowing insurers to offer plans with smaller mandatory coverage lists, or permitting tiered plans with graduated co‑payments. However, consumer advocacy groups resist any rollback of coverage guarantees.

F. Portability and Risk Equalization

Easier portability (switching plans without waiting periods) and risk‑equalization pools could spread costs across the entire market and discourage adverse selection. Brazil has taken initial steps, but implementation is incomplete.

Expert Insights: What Do Industry Leaders Say?

We spoke with Dr. Renato de Souza, a health economist at the Getulio Vargas Foundation (FGV), who has studied Brazil’s supplementary health sector for two decades.

“The current model is unsustainable. We have a system where premiums are set by medical inflation, but medical inflation is driven by a combination of aging, innovation, and a culture of overconsumption. Without structural changes—like shifting to a value‑based system or expanding public‑private partnerships—premiums will continue to outpace household income growth.”

He adds that judicialization is the “wild card”:

“If the courts keep expanding coverage beyond what was contracted, insurers will have no choice but to charge everyone more. We need clear, binding rules that respect the actuarial balance of plans.”

Meanwhile, Mariana Albuquerque, CEO of a midsize insurance brokerage in São Paulo, observes that clients are becoming smarter shoppers:

“Five years ago, most people chose plans based on brand recognition. Now they ask about network restrictions, co‑payments, and annual adjustment caps. They’re willing to sacrifice some comfort for affordability.”

Future Outlook: Where Are Premiums Headed?

Based on current trends, the outlook for 2025–2030 suggests:

Annual adjustments: Individual plans likely to see increases of 8–12% per year, corporate plans 10–15% .
Consolidation: More mergers among hospitals and insurers, potentially reducing competition in some regions.
Technology both a cost driver and a cost saver. Gene therapies will add pressure, but AI‑driven administrative efficiencies may offset some inflation.
Regulation: The ANS will likely introduce more flexibilization to allow lower‑cost plan options, but consumer protection laws will prevent drastic changes.
Demographics: The aging tide is unstoppable; by 2035, the over‑60 segment will be the fastest‑growing insurance cohort.

In summary, premiums will keep rising—but perhaps at a slower rate if market reforms succeed.

Final Thoughts

The rising cost of Brazil’s planos de saúde is not a simple story. It’s a complex interplay of medical progress, an ageing population, legal activism, regulatory costs, and economic pressures. For consumers, the takeaway is clear: understanding your plan, your rights, and your options has never been more important.

Whether you are an individual shopping for personal coverage or an employer managing a corporate plan, being informed can help you navigate this challenging landscape. Start by exploring the related resources we provide—each addresses a key aspect of the Brazilian health insurance market.

The road ahead is challenging, but with the right knowledge, you can make smarter healthcare decisions—and perhaps even influence the direction of reform in one of the world’s most fascinating health insurance markets.